Author Archives: Megan Thomas

#Life sciences #Report

Life science report released on shaping the life sciences industry

Global law firm Hogan Lovells has released its fourth annual Life Sciences and Health Care Horizons report, which takes an in-depth look at the opportunities, evolving trends and challenges shaping the future of the life sciences and health care industry. It provides “a high level overview of the potential opportunities,… Read More

#News

#Diagnostics #Drug development #Drug discovery #Webinar

Why hepatocytes are enabling antimalarial drug discovery

BioIVT, providers of research models and services for drug and diagnostic development, will be hosting a webinar where researchers from the University of Georgia will explain the first medium-throughput, 384-well plate-based liver-stage antimalarial drug discovery platform which they have developed. The webinar, entitled Identifying the Critical Factors Enabling a Phenotypic… Read More

#News

#Big pharma #Biopharmaceuticals #Biotechnology #Covid-19 #Vaccines

Supply chains key to successful COVID-19 vaccine roll-out 

Resilience in pharma and biotech supply chains is essential for the roll out of the Covid-19 vaccine, says Karl Lauri, ERP/MRP software manufacturer and distributor MRPeasy.com.  While the pandemic has highlighted the strength of the UK’s pharmaceutical and biotechnology sector, it has also shed light on the vulnerabilities of intricate, geographically extended and… Read More

#Covid-19 #News

#Assay development optimisation & technology #Covid-19 #Immunology / Virology & Vaccines

Bio-Rad launches new SARS-CoV-2 serology assay panel

Bio-Rad’s Bio-Plex Pro Human IgG SARS-CoV-2 N/RBD/S1/S2 4-Plex Panel is a ready-to-use, qualitative multiplex immunoassay panel which has been designed to provide quick, precise detection of IgG antibodies against four SARS-CoV-2 antigens. This “provides useful information about natural exposure rates in a population or about vaccine immunogenicity,” said Candice Cox,… Read More

#Covid-19 #News